Working... Menu

Treatment of Diabetic Macular Edema With Aflibercept in Subjects Previously Treated With Ranibizumab or Bevacizumab (SwapTwo)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02559180
Recruitment Status : Recruiting
First Posted : September 24, 2015
Last Update Posted : January 26, 2018
Regeneron Pharmaceuticals
Information provided by (Responsible Party):
Rishi Singh, The Cleveland Clinic